Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPOD
5576
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
| $1.87M | ﹤0.01% |
187,931
+102,511
| +120% | +$1.03M |
|
5577
CALL
MarineMax
HZO
$1.15B
| $1.86M | ﹤0.01% |
51,600
-500
| -1% | -$20.1K |
|
5578
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.21B
| $1.86M | ﹤0.01% |
38,615
-231,420
| -86% | -$11.4M |
|
|
MTTR
5579
CALL
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $1.86M | ﹤0.01% |
509,000
-21,900
| -4% | -$120K |
|
5580
CALL
Vipshop
VIPS
$6.75B
| $1.86M | ﹤0.01% |
188,300
-87,700
| -32% | -$772K |
|
5581
CALL
Sensient Technologies
SXT
$5.68B
| $1.86M | ﹤0.01% |
23,100
+14,500
| +169% | +$1.2M |
|
|
DCT
5582
CALL
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $1.86M | ﹤0.01% |
125,200
+29,200
| +30% | +$513K |
|
5583
CALL
Costamare
CMRE
$1.81B
| $1.86M | ﹤0.01% |
153,400
-33,900
| -18% | -$471K |
|
|
TRTX
5584
TPG RE Finance Trust
TRTX
$609M
| $1.86M | ﹤0.01% |
205,925
-103,369
| -33% | -$1.08M |
|
|
HLTH
5585
CALL
DELISTED
Cue Health Inc. Common Stock
HLTH
| $1.85M | ﹤0.01% |
579,600
+372,300
| +180% | +$2.02M |
|
|
SNV
5586
PUT
DELISTED
Synovus
SNV
| $1.85M | ﹤0.01% |
51,400
-4,900
| -9% | -$203K |
|
5587
BJ's Restaurants
BJRI
$1.41B
| $1.85M | ﹤0.01% |
85,359
-46,562
| -35% | -$1.2M |
|
5588
CALL
Design Therapeutics
DSGN
$946M
| $1.85M | ﹤0.01% |
+132,200
| New | +$1.79M |
|
|
AMRN
5589
Amarin Corp
AMRN
$296M
| $1.85M | ﹤0.01% |
62,084
-58,207
| -48% | -$2.51M |
|
5590
First Trust Cloud Computing ETF
SKYY
$3.31B
| $1.85M | ﹤0.01% |
+28,077
| New | +$2.07M |
|
|
AVAN
5591
CALL
DELISTED
Avanti Acquisition Corp.
AVAN
| $1.85M | ﹤0.01% |
186,700
+158,900
| +572% | +$1.57M |
|
5592
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
$1.26B
| $1.85M | ﹤0.01% |
21,053
+6,681
| +46% | +$645K |
|
5593
NextCure
NXTC
$35.3M
| $1.85M | ﹤0.01% |
32,781
+282
| +0.9% | +$14.7K |
|
5594
CALL
Cytokinetics
CYTK
$10.5B
| $1.85M | ﹤0.01% |
47,000
+29,800
| +173% | +$1.2M |
|
5595
PUT
Hilton Grand Vacations
HGV
$3.49B
| $1.85M | ﹤0.01% |
51,700
+43,300
| +515% | +$1.93M |
|
5596
PUT
Woodside Energy
WDS
$44.8B
| $1.85M | ﹤0.01% |
+85,688
| New | +$1.94M |
|
|
CUTR
5597
DELISTED
Cutera, Inc.
CUTR
| $1.85M | ﹤0.01% |
49,227
+8,134
| +20% | +$429K |
|
5598
CALL
Amplify Alternative Harvest ETF
MJ
$110M
| $1.84M | ﹤0.01% |
26,492
-9,033
| -25% | -$836K |
|
5599
Karyopharm Therapeutics
KPTI
$40.6M
| $1.84M | ﹤0.01% |
27,223
-29,745
| -52% | -$2.73M |
|
5600
CALL
Customers Bancorp
CUBI
$2.78B
| $1.84M | ﹤0.01% |
54,300
-10,400
| -16% | -$423K |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.